217 related articles for article (PubMed ID: 31801039)
1. Determinants of (non-)attendance at the Dutch cancer screening programmes: A systematic review.
Bongaerts TH; Büchner FL; Middelkoop BJ; Guicherit OR; Numans ME
J Med Screen; 2020 Sep; 27(3):121-129. PubMed ID: 31801039
[TBL] [Abstract][Full Text] [Related]
2. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
[TBL] [Abstract][Full Text] [Related]
3. Concurrent participation in screening for cervical, breast, and bowel cancer in England.
Rebolj M; Parmar D; Maroni R; Blyuss O; Duffy SW
J Med Screen; 2020 Mar; 27(1):9-17. PubMed ID: 31525303
[TBL] [Abstract][Full Text] [Related]
4. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
[TBL] [Abstract][Full Text] [Related]
5. Are smokers less likely to seek preventive healthcare measures in Italy?
Carreras G; Iannucci L; Costa G; Chellini E; Gorini G
Eur J Cancer Prev; 2018 Sep; 27(5):507-513. PubMed ID: 28379886
[TBL] [Abstract][Full Text] [Related]
6. Determinants of cancer screenings participation in Queensland: a scoping review.
Lui PSC; Singh K; Nguyen T; Kurth B; Phan T; Nelson A; Danisevska R; De Ambrosis T
J Prim Health Care; 2024 Mar; 16(1):70-77. PubMed ID: 38546768
[TBL] [Abstract][Full Text] [Related]
7. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.
Dressler J; Johnsen AT; Madsen LJ; Rasmussen M; Jorgensen LN
Public Health; 2021 Jan; 190():67-74. PubMed ID: 33360029
[TBL] [Abstract][Full Text] [Related]
9. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N
Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514
[TBL] [Abstract][Full Text] [Related]
10. Perceptions and beliefs of general practitioners on their role in the cancer screening programmes in the Netherlands: a mixed-methods study.
Bongaerts THG; Büchner FL; Nierkens V; Crone MR; Guicherit OR; Numans ME
BMC Prim Care; 2024 Apr; 25(1):129. PubMed ID: 38658815
[TBL] [Abstract][Full Text] [Related]
11. Effect of financial incentives on breast, cervical and colorectal cancer screening delivery rates: Results from a systematic literature review.
Mauro M; Rotundo G; Giancotti M
Health Policy; 2019 Dec; 123(12):1210-1220. PubMed ID: 31587819
[TBL] [Abstract][Full Text] [Related]
12. Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe.
Toes-Zoutendijk E; Portillo I; Hoeck S; de Brabander I; Perrin P; Dubois C; van Leerdam M; Lansdorp-Vogelaar I; Bardou M
J Med Screen; 2020 Jun; 27(2):68-76. PubMed ID: 31645173
[TBL] [Abstract][Full Text] [Related]
13. Attendance characteristics of the breast and colorectal cancer screening programmes in a highly urbanised region of the Netherlands: a retrospective observational study.
Bongaerts THG; Büchner FL; de Munck L; Elferink MAG; Guicherit OR; Numans ME
BMJ Open; 2023 Jun; 13(6):e071354. PubMed ID: 37355264
[TBL] [Abstract][Full Text] [Related]
14. Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey.
Park B; Choi KS; Lee YY; Jun JK; Seo HG
Asian Pac J Cancer Prev; 2012; 13(4):1187-91. PubMed ID: 22799303
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening participation: a systematic review.
Wools A; Dapper EA; de Leeuw JR
Eur J Public Health; 2016 Feb; 26(1):158-68. PubMed ID: 26370437
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes†.
Dawidowicz S; Le Breton J; Moscova L; Renard V; Bercier S; Brixi Z; Audureau E; Clerc P; Bastuji-Garin S; Ferrat E
Fam Pract; 2020 Feb; 37(1):15-24. PubMed ID: 31305884
[TBL] [Abstract][Full Text] [Related]
17. Determinants of cancer screening awareness and participation among Indonesian women.
Anwar SL; Tampubolon G; Van Hemelrijck M; Hutajulu SH; Watkins J; Wulaningsih W;
BMC Cancer; 2018 Mar; 18(1):208. PubMed ID: 29506486
[TBL] [Abstract][Full Text] [Related]
18. "It's cancer screening after all". Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening.
Kirkegaard P; Larsen MB; Andersen B
J Med Screen; 2023 Jun; 30(2):74-80. PubMed ID: 36541340
[TBL] [Abstract][Full Text] [Related]
19. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women.
Bosgraaf RP; Ketelaars PJ; Verhoef VM; Massuger LF; Meijer CJ; Melchers WJ; Bekkers RL
Prev Med; 2014 Jul; 64():108-13. PubMed ID: 24736093
[TBL] [Abstract][Full Text] [Related]
20. The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review.
Spadea T; Bellini S; Kunst A; Stirbu I; Costa G
Prev Med; 2010 Apr; 50(4):159-64. PubMed ID: 20093138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
